Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

38.90p
   
  • Change Today:
    -1.10p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.39m
  • Volume: 317,562
  • Market Cap: £210.21m
  • RiskGrade: 119
  • Beta: 0.72

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart (05-12-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 4.6% 0.0%
Div Cover 2.4 3.0
Op Mrgn 6.3% 23.1%
ROCE 16.2%  
Latest F'cast
P/E 9.1 8.6
PEG n/a 1.6
Pr/Revenue 1.3 1.2
Pr/Book 0.7  
Latest F'cast
Revenue 2.6% 9.1%
PBT -71.3% 709.6%
EPS -33.0% 5.4%
DPS 5.0% -16.1%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 5.21 4.28p 12.4 n/a -33% 1.78p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 182.73 42.16 4.51p 8.6 1.6 +5% 1.49p 0.0%
31-Dec-24 198.24 46.93 5.40p 7.2 0.4 +20% 1.51p 0.0%
31-Dec-25 215.91 52.22 6.42p 6.1 0.3 +19% 1.57p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 01-Dec-2023 12:23 RNS
Notification of Major Holdings 09-Nov-2023 11:17 RNS
Appointment of Non-Executive Directors 07-Nov-2023 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma confident after some first-half ... 26-Sep-2023 ShareCast
Alliance Pharma reports resilient first-half tra... 18-Jul-2023 ShareCast
Currency headwinds to impact Alliance Pharma pro... 25-May-2023 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 38.90p
Change Today -1.10p
% Change -2.75 %
52 Week High 71.80
52 Week Low 34.50
Volume 317,562
Shares Issued 540.39m
Market Cap £210.21m
Beta 0.72
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.60% above the market average85.60% above the market average85.60% above the market average85.60% above the market average85.60% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Price Trend
62.01% below the market average62.01% below the market average62.01% below the market average62.01% below the market average62.01% below the market average
22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average22.03% below the sector average
Income
42.86% above the market average42.86% above the market average42.86% above the market average42.86% above the market average42.86% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 05-Dec-2023

Time Volume / Share Price
16:35 40,056 @ 38.90p
16:35 491 @ 38.90p
16:35 1,091 @ 38.90p
16:35 1,649 @ 38.90p
16:35 2,012 @ 38.90p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page